Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/127378| Title: | Translating '–omics' results into precision medicine for hepatocellular carcinoma |
| Author: | Sia, Daniela Llovet i Bayer, Josep Maria |
| Keywords: | Càncer de fetge Immunoteràpia Liver cancer Immunotherapy |
| Issue Date: | 2-Aug-2017 |
| Publisher: | Nature Publishing Group |
| Abstract: | A large-scale comprehensive analysis of hepatocellular carcinoma (HCC) based on the integration of six distinct data platforms has pinpointed novel oncogenic processes and prognostic subgroups. These findings confirm previously identified molecular subclasses and fuel the need for a clear strategy of precision medicine in HCC. |
| Note: | Versió posprint del document publicat a: https://doi.org/10.1038/nrgastro.2017.103 |
| It is part of: | Nature Reviews Gastroenterology & Hepatology, 2017, vol. 14, p. 571-572 |
| URI: | http://hdl.handle.net/2445/127378 |
| Related resource: | https://doi.org/10.1038/nrgastro.2017.103 |
| Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Medicina) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 3.Sia D 2018 Nat Rev Gastr Hepatol.pdf | 289.46 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.